Ubrelvy

This page shows the latest Ubrelvy news and features for those working in and with pharma, biotech and healthcare.

Biohaven gets FDA approval for migraine drug Nurtec ODT

The new drug’s approval by the FDA follows the agency’s green light for Allergan’s Ubrelvy (ubrogepant) in December. ... That is slightly lower than the $4, 896 annual list price for Ubrelvy, according to ICER.

Latest news

Lundbeck gets US approval for migraine drug at heart of Alder takeover

The product category has extended with an orally-active CGRP drug in December when Allergan secured FDA approval for Ubrelvy (ubrogepant), though this isn’t a direct competitor as it is
Botox strength bolsters Allergan ahead of AbbVie takeover

Allergan chief executive Brent Saunders said Allergan is entering 2020 with “strong momentum”, helped by approvals such as an FDA green light for new acute migraine therapy Ubrelvy (ubrogepant).
Lilly launches migraine med Reyvow at $640 per eight-pill pack

Its closest competitor is Allergan’s Ubrelvy (ubrogepant) – an oral CGRP inhibitor which also has FDA approval in the treatment of acute migraine, with or without aura.
Allergan gets FDA nod for first oral CGRP drug for migraine

The US regulator has given a green light to Ubrelvy (ubrogepant) for acute migraine with or without aura, and Ireland-domiciled Allergan says it intends to launch the drug in the ... Atogepant is expected to account for the bulk of Allergan’s sales
Allergan’s oral migraine drug closer to US filing

New data keeps Allergan ahead of rival Biohaven

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Cortellis Drugs to Watch in 2020 report

To succeed in the acute treatment setting, rimegepant will also have to beat competitors like Reyvow and Ubrelvy, both of which are also oral drugs with very attractive profiles. ... Allergan’s Ubrelvy is the only other oral CGRP antagonist approved

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

Medical Editor: Competitive

Account Director – Creative Healthcare Communications: Competative

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Lead Copywriter: Competitive

Healthcare Senior Account Manager: Competitive

PMHub

Add my company

Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...